1 – 40 of 40
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Apathy and anxiety are early markers of Alzheimer's disease
(
- Contribution to journal › Article
- 2019
-
Mark
A comprehensive screening of copy number variability in dementia with Lewy bodies
(
- Contribution to journal › Article
- 2018
-
Mark
Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake
(
- Contribution to journal › Article
- 2016
-
Mark
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.
(
- Contribution to journal › Article
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement.
2016) 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 39(Suppl. 1). p.2-2(
- Contribution to journal › Published meeting abstract
-
Mark
Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease
(
- Contribution to journal › Article
- 2015
-
Mark
The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.
(
- Contribution to journal › Article
-
Mark
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
(
- Contribution to journal › Article
-
Mark
Suspected non-AD pathology in mild cognitive impairment
(
- Contribution to journal › Article
- 2014
-
Mark
Wide-spread age-related differences in human brain microstructure revealed by quantitative MRI
(
- Contribution to journal › Article
-
Mark
Factors that affect life-span in mild versus moderate Alzheimer’s disease.
2014) 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 35(Suppl. 1). p.25-25(
- Contribution to journal › Published meeting abstract
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
-
Mark
Longitudinal neurochemical modifications in the aging mouse brain measured in vivo by 1H magnetic resonance spectroscopy
(
- Contribution to journal › Article
-
Mark
Hippocampal subfield volumes at 7T in early Alzheimer's disease and normal aging
(
- Contribution to journal › Article
- 2013
-
Mark
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease
(
- Contribution to journal › Article
- 2012
-
Mark
Normal aging reduces motor synergies in manual pointing
(
- Contribution to journal › Article
-
Mark
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Spatial navigation training protects the hippocampus against age-related changes during early and late adulthood
(
- Contribution to journal › Article
-
Mark
The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent
(
- Contribution to journal › Article
-
Mark
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
(
- Contribution to journal › Article
-
Mark
Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion.
2012) In Neurobiology of Aging(
- Contribution to journal › Article
- 2011
-
Mark
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
(
- Contribution to journal › Article
- 2010
-
Mark
Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment.
(
- Contribution to journal › Article
-
Mark
Evaluation of plasma A beta(40) and A beta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Evaluation of plasma A beta 40 and A beta 42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment Response
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.
(
- Contribution to journal › Article
- 2009
-
Mark
The PPAR-alpha gene in Alzheimer's disease: Lack of replication of earlier association
(
- Contribution to journal › Article
-
Mark
A link between sICAM-1, ACE and parietal blood flow in the aging brain.
(
- Contribution to journal › Article
-
Mark
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Modification upon aging of the density of presynaptic modulation systems in the hippocampus
(
- Contribution to journal › Article
- 2008
-
Mark
Complete ascertainment of Parkinson disease in the Swedish Twin Registry
(
- Contribution to journal › Article
-
Mark
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.
2008) In Neurobiology of Aging(
- Contribution to journal › Article
- 2007
-
Mark
Effects of Alzheimer's peptide and alpha 1-antichymotrypsin on astrocyte gene expression
(
- Contribution to journal › Article
-
Mark
Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression
2007) In Neurobiology of Aging(
- Contribution to journal › Article
- 2006
-
Mark
White matter mapping in Alzheimer's disease: A neuropathological study.
(
- Contribution to journal › Article
- 2005
-
Mark
Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning.
(
- Contribution to journal › Article
- 1998
-
Mark
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease
(
- Contribution to journal › Article